Lv5
968 积分 2020-11-18 加入
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
4天前
已完结
A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease
4天前
已完结
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
4天前
已完结
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
4天前
已完结
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial
4天前
已完结
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
4天前
已完结
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
4天前
已完结
A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy
4天前
已完结
Mitochondrial metabolism and epigenetic crosstalk drive SASP
10天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
11天前
已完结
皖公网安备34019202002308
